The proportion of HCV genotypes was significantly different between the two groups; however, the improvement in histological fibrosis was significant in both groups, even in patients with HCV genotype 1 (IFN-based DAA group; n = 23, IFN-free DAA group n = 39; Supplementary Figure S5). This evidence concerns the gene IFNA1 and fibrosis.